Biologic therapy-Related demyelinating peripheral neuropathy in a child with Juvenile Idiopathic Arthritis

Journal Title: Archives of Pharmacy and Pharmaceutical Sciences - Year 2018, Vol 2, Issue 1

Abstract

Demyelinating peripheral neuropathy has been described in association with tumor necrosis factor (TNF) inhibitors. It is rarely developed after treatment discontinuation. We present the case of a child with juvenile idiopathic arthritis who developed peripheral neuropathy few months after TNF inhibitor withdrawal with clinical worsening of the neurological sequelae while undergoing treatment with abatacept.

Authors and Affiliations

Heba A Alqurashi, Ghada Al-Salmi, Mohammad A Al-Muhaizea, Sulaiman M Al-Mayouf

Keywords

Related Articles

Preparation, solid state characterization and evaluation of ketoprofen-glucosamine HCl solid dispersions

In this investigation, solid dispersions were prepared and characterized to improve the solubility and dissolution of poorly water soluble drug Ketoprofen, using glucosamine HCl as a carrier. For the improvement of the s...

Kinematics and Electromyographic Analysis of Gait with Different Footwear

Kinematic analysis and surface electromyography are tools being used as important methods to evaluate the human gait and to analyze different types of footwear aiming modifications and adaptations to the human locomotor...

Nano-formulations for Ophthalmic Treatments

Ocular disorders encompass a multitude of diseases that are unique in their cause, therapy and degree of severity. Due to distinctive morphology of the eye, efficient ocular drug delivery has proven to be a difficult tas...

Paediatric Medicines: Formulation Considerations

The use of unlicensed and off-label medicines in children is widespread and has raised an increasing concern over the last years. The majority of medicines taken by children are extemporaneously compounded by pharmacist,...

Biologic therapy-Related demyelinating peripheral neuropathy in a child with Juvenile Idiopathic Arthritis

Demyelinating peripheral neuropathy has been described in association with tumor necrosis factor (TNF) inhibitors. It is rarely developed after treatment discontinuation. We present the case of a child with juvenile idio...

Download PDF file
  • EP ID EP560284
  • DOI 10.29328/journal.apps.1001008
  • Views 57
  • Downloads 0

How To Cite

Heba A Alqurashi, Ghada Al-Salmi, Mohammad A Al-Muhaizea, Sulaiman M Al-Mayouf (2018). Biologic therapy-Related demyelinating peripheral neuropathy in a child with Juvenile Idiopathic Arthritis. Archives of Pharmacy and Pharmaceutical Sciences, 2(1), 20-22. https://europub.co.uk./articles/-A-560284